Canadian Markets open in 7 hrs 17 mins

Spectrum Pharmaceuticals, Inc. (SPPI)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.61-0.25 (-3.18%)
At close: 4:00PM EDT
People also watch
KERXVNDARIGLOREXBDSI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close7.86
Open7.85
Bid2.95 x 100
Ask8.35 x 100
Day's Range7.58 - 7.89
52 Week Range3.21 - 8.00
Volume575,519
Avg. Volume854,945
Market Cap604.51M
Beta1.77
PE Ratio (TTM)-8.09
EPS (TTM)-0.94
Earnings DateMar 7, 2017 - Mar 13, 2017
Dividend & Yield0.00 (0.00%)
Ex-Dividend Date2012-12-18
1y Target Est9.83
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    ETFs with exposure to Spectrum Pharmaceuticals, Inc. : April 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Spectrum Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SPPI-US. Comparing the performance and risk of Spectrum Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Business Wire4 days ago

    Spectrum Pharmaceuticals to Present Corporate Update at the 42nd Annual Deutsche Bank Health Care Conference on May 4

    Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the 42nd Annual Deutsche Bank Health Care Conference being held at The InterContinental Boston Hotel in Boston....

  • Business Wire6 days ago

    Spectrum Pharmaceuticals Announces First Quarter 2017 Financial Results Teleconference and Webcast

    Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced it will host a teleconference and webcast with management to discuss the first quarter 2017 financial results, provide an update on the Company's business, and discuss expectations for the future.